MedRhythms snatches up $25m Series B

MedRhythms, a developer of prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease, has raised $25 million in Series B financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this